PRIMENENIE PROSTAGUT FORTE U BOL'NYKh ADENOMOY PREDSTATEL'NOY ZhELEZY S SOPUTSTVUYuShchIM KhRONIChESKIM PROSTATITOM
- Authors: Avdoshin V.P1, Pulbere S.A1
-
Affiliations:
- Issue: No 2 (2012)
- Pages: 44-47
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/279422
- ID: 279422
Cite item
Open Access
Access granted
Abstract
The study consisting of four visits included 69 patients with prostatic adenoma and concomitant chronic prostatitis. The patients received either monotherapy with an alpha adrenoblocker or combined treatment including phytodrug prostagut forte. The results of the study showed that the above combined treatment produces more pronounced and persistent improvement of urodynamic indices, leads to reduction of leukocyte count in the urine and prostatic secretion, upgrades quality of life. The absence of side effects allows recommendation of prostagut forte for treatment of presenile and senile patients with prostatic adenoma and associated pathology.
Full Text
References
- Гориловский Л. М., Зингеренко М. Б. Доброкачественная гиперплазия предстательной железы — актуальная проблема гериатрической урологии. Consilium Medicum 2003; 5 (12): 732—735.
- Emberton M. The hallmarks of BPH progression and risk factors. Eur. Urol. Suppl. 2003; 2 (8): 2—7.
- Лопаткин Н. А. (ред.). Руководство по клинической урологии. М.; 1999; т. 2.
- Textbook of benign prostatic hyperplasia.; 1996.
Supplementary files
